MedTrace Logo

Whole-body Vibration Versus Gravity Force Stimulation on Postural Stability in Children With Duchene Muscular Dystrophy

NCT07780435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-21

No results posted yet for this study

Summary

this study aimed to mention Does whole-body vibration training or gravity-force stimulation produce greater improvements in postural stability among children with Duchenne Muscular Dystrophy?

Conditions

  • Duchene Muscular Dystrophy

Interventions

PROCEDURE

force gravity stimulation

Thirty children received: • Gravity-Force Stimulation (GFS), which included: * Exercises will be designed to enhance postural control and trunk stability while exposed to controlled gravitational loading. * Active or active-assisted stabilization exercises performed while experiencing graded gravitational forces. * Arm exercises performed with the trunk stabilized to challenge neuromuscular control under increased gravitational demand. * Trunk mobilization exercises (in sitting and lying positions) performed under conditions simulating increased gravitational load. * Functional reaching activities with varied ranges of shoulder elevation, supported by the physiotherapist to ensure proper control during gravitational stimulation.

PROCEDURE

whole body vibration

we use vibrating platform •

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mostafa S. Ali · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-10
Primary Completion
2026-05-15
Completion
2026-08-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07780435 on ClinicalTrials.gov